Related Experiment Video
Updated: Aug 14, 2026

08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
SurroDock: A Deep Learning Surrogate for Accelerated Pre-Docking Ligand Prioritization in Structure-Based Virtual
1Department of Chemical & Biological Engineering, Chungwoon University, Incheon 22100, Republic of Korea.
International Journal of Molecular Sciences
|August 13, 2026
Summary
SurroDock, a deep-learning model, efficiently pre-filters compounds for virtual screening by approximating docking scores using 2D molecular features, significantly reducing computational costs.
Area of Science:
- Computational Chemistry
- Drug Discovery
- Machine Learning
Background:
- Virtual screening is crucial for drug discovery but computationally intensive.
- Large chemical libraries pose challenges for exhaustive structure-based virtual screening.
- Existing methods struggle with the scale of make-on-demand and public chemical databases.
Purpose of the Study:
- To develop SurroDock, a deep-learning surrogate model for rapid approximation of AutoDock Vina docking scores.
- To serve as a pre-filter for structure-based virtual screening, enhancing efficiency.
- To evaluate SurroDock's performance on estrogen receptor alpha using agonist and antagonist-bound states.
Main Methods:
- Trained a deep-learning model on concatenated 2D molecular representations (fingerprints, descriptors).
- Utilized a dataset of ~334,000 compounds docked with AutoDock Vina against two estrogen receptor alpha conformations (1GWR, 3ERT).
- Evaluated model performance using R-squared values and retrospective screening enrichment factors.
Main Results:
- SurroDock achieved high R-squared values (0.88 for 1GWR, 0.93 for 3ERT) on held-out validation data.
- Demonstrated significant enrichment (EF@1% ~57-61 fold) in recovering top-ranked compounds.
- Showcased state-specific modeling effectiveness due to distinct docking-score distributions between receptor conformations.
Conclusions:
- 2D-based docking-score surrogate modeling offers a reproducible and retrainable strategy for large-scale virtual screening.
- SurroDock effectively concentrates docking resources on a smaller, enriched subset of compounds.
- SurroDock predictions are valuable prioritization aids, requiring complementary experimental validation.
Related Concept Videos
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
